Aaron Wainwright moves across from blindside flanker to fill the void at number eight created by Faletau’s injury, while skipper Jac Morgan takes the number six shirt.

Source: https://jerseyeveningpost.com/uksport/2023/10/12/dan-biggar-and-liam-williams-fit-for-wales-quarter-final-against-argentina/

Additionally, Fast and Furious Presents: Hobbs & ShawBenjamin Wainwright Laurence Ubong Williams) are also set to be part of the voice cast.

Source: https://collider.com/the-lord-of-the-rings-the-war-of-the-rohirrim-anime-prequel-movie-release-date-cast-plot/

Alpine Immune Sciences ( had its target price upped by HC Wainwright from $8.00 to $11.00 in a report issued on Friday morning, reports.

Source: https://www.dailypolitical.com/2023/03/27/alpine-immune-sciences-nasdaqalpn-pt-raised-to-11-00.html

Award winners (left to right) Jeffrey Lesser of the Halle Institute, Daphne Orr of Emory’s Oxford College, and Kim Woo-taek of Next Entertainment World, pose with Vice Provost Philip Wainwright.

Source: https://www.globalatlanta.com/emory-honors-faculty-alumni-for-deepening-international-connections/

Blueprint Medicines ( had its price objective hoisted by HC Wainwright from $70.00 to $75.00 in a note issued to investors on Friday, reports.

Source: https://www.etfdailynews.com/2023/05/07/blueprint-medicines-nasdaqbpmc-pt-raised-to-75-00-at-hc-wainwright/

Charges under the Workers Compensation Act were laid last month against the tug company, Wainwright Marine Services, and one of its senior officials, alleging violations of occupational health and safety regulations.

Source: https://energeticcity.ca/2023/03/08/safety-board-to-release-report-on-b-c-tug-sinking-that-claimed-two-lives/

Dave Wainwright, now commercial operations director (North East) at Thurra, added: “This is a very positive move for Plant Inspection Services, our clients and team.

Source: https://www.lancashiretelegraph.co.uk/news/23430926.rawtenstalls-thurra-acquires-engineering-inspections-firm/?ref=rss

Finally, HC Wainwright boosted their price target on Catalyst Pharmaceuticals from $18.00 to $24.00 and gave the stock a “buy” rating in a research note on Wednesday, December 21st.

Source: https://www.etfdailynews.com/2023/01/31/barclays-plc-boosts-stake-in-catalyst-pharmaceuticals-inc-nasdaqcprx/

Finally, HC Wainwright decreased their target price on shares of Checkpoint Therapeutics from $76.00 to $34.00 in a research note on Friday, April 28th.

Source: https://www.dailypolitical.com/2023/05/31/checkpoint-therapeutics-nasdaqckpt-pt-lowered-to-16-00.html

Finally, HC Wainwright dropped their price target on Inozyme Pharma from $19.00 to $16.00 and set a “buy” rating on the stock in a research report on Friday, August 4th.

Source: https://www.americanbankingnews.com/2023/11/19/acadian-asset-management-llc-invests-319000-in-inozyme-pharma-inc-nasdaqinzy.html

Finally, HC Wainwright reaffirmed a buy rating and issued a $6.00 price target on shares of Clearside Biomedical in a report on Tuesday, August 15th.

Source: https://www.etfdailynews.com/2023/10/27/clearside-biomedical-nasdaqclsd-research-coverage-started-at-stocknews-com/

Finally, HC Wainwright reiterated a “buy” rating and issued a $50.00 price objective on shares of Anavex Life Sciences in a report on Monday, February 6th.

Source: https://www.etfdailynews.com/2023/03/12/anavex-life-sciences-corp-nasdaqavxl-shares-sold-by-alphacrest-capital-management-llc/

Finally, HC Wainwright restated a “buy” rating and set a $6.00 price objective on shares of Affimed in a research report on Friday, March 24th.

Source: https://www.dailypolitical.com/2023/05/11/affimed-nasdaqafmd-stock-price-passes-above-50-day-moving-average-of-0-80.html

HC Wainwright also issued estimates for Kiora Pharmaceuticals’ Q1 2024 earnings at ($0.30) EPS, Q2 2024 earnings at ($0.26) EPS, Q3 2024 earnings at ($0.26) EPS and Q4 2024 earnings at ($0.26) EPS.

Source: https://www.etfdailynews.com/2023/05/14/kiora-pharmaceuticals-nasdaqkprx-pt-raised-to-7-00-at-hc-wainwright/

HC Wainwright analyst E. Arce forecasts that the company will earn ($1.38) per share for the year.

Source: https://www.americanbankingnews.com/2023/04/04/axcella-health-inc-forecasted-to-earn-fy2027-earnings-of-1-38-per-share-nasdaqaxla.html

HC Wainwright boosted their price target on shares of CymaBay Therapeutics from $10.00 to $12.00 in a research report on Friday, March 17th.

Source: https://www.etfdailynews.com/2023/04/18/cymabay-therapeutics-inc-nasdaqcbay-insider-sells-69873-38-in-stock/

H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering.

Source: https://www.marketscreener.com/quote/stock/MICROBOT-MEDICAL-INC-45615636/news/Microbot-Medical-Announces-1-4-Million-Registered-Direct-Offering-of-Common-Stock-Priced-At-The-Mar-43918369/?utm_medium=RSS&utm_content=20230522

HC Wainwright currently has a $5.00 target price on the stock.

Source: https://www.etfdailynews.com/2023/03/30/adagene-nasdaqadag-earns-buy-rating-from-hc-wainwright/

HC Wainwright decreased their price target on shares of Mirum Pharmaceuticals from $69.00 to $61.00 and set a “buy” rating on the stock in a research note on Wednesday, February 15th.

Source: https://www.etfdailynews.com/2023/02/24/connor-clark-lunn-investment-management-ltd-sells-3784-shares-of-mirum-pharmaceuticals-inc-nasdaqmirm/

HC Wainwright dropped their price objective on shares of Hecla Mining from $9.25 to $9.00 and set a “buy” rating on the stock in a report on Tuesday, September 19th.

Source: https://www.etfdailynews.com/2023/10/04/charles-schwab-trust-co-invests-67000-in-hecla-mining-nysehl/